Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies

Clinical trial NCT06904066 · RECRUITING

Trial details

NCT number: NCT06904066
Sponsor: National Cancer Institute (NCI)
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Malignancy, Hematologic Neoplasms, Hematologic Neoplasms, Hematopoietic Blood Cancer Hematological Neoplasms Hematopoietic Malignancies Dysmyelopoietic Syndromes Hematopoetic Myelodysplasia Myeloid Leukemia, Acute Nonlymphoblastic Leukemia, Acute Leukemia, Lymphocytic, Acute

Start date: 2026-08-26
Primary completion: 2029-04-30
Enrollment: 86

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.